Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$1.84 - $6.44 $28,152 - $98,532
-15,300 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$1.54 - $6.75 $49,434 - $216,675
-32,100 Reduced 67.72%
15,300 $33,000
Q4 2019

Feb 11, 2020

BUY
$3.06 - $8.78 $145,044 - $416,171
47,400 New
47,400 $275,000
Q2 2019

Aug 12, 2019

SELL
$3.72 - $6.95 $43,152 - $80,620
-11,600 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$5.74 - $8.05 $66,584 - $93,380
11,600 New
11,600 $80,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $245M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.